Poorer educational outcomes may need to be added to the list of the potential outcomes for children who have type 1 diabetes.
Poorer educational outcomes may need to be added to the list of the potential outcomes for children who have type 1 diabetes. A new study published in Diabetes Care examines the connection.
Researchers used 9 databases from across Scotland that included hospital admissions, maternity records, dispensed prescriptions, diabetes registered, death certificates, school absences/exclusions, school examination, annual pupil census, and unemployment, which resulted in a cohort of 766,047 single-birth children who were born and attended school in Scotland between 2009 and 2013. Within that cohort, 3330 children were treated for type 1 diabetes.
The children treated for type 1 diabetes were more likely than their peers who did not have the condition to be absent from school, have some form of learning difficulty, be admitted to a hospital, and die. In the cohort of children with type 1 diabetes, the children with a higher HbA1c measurement, particularly those with a measurement in the highest quintile, were more likely to have an increased risk of exclusion, a greater rate of absenteeism, poorer attainment of education, and a higher risk of being unemployed.
The researchers highlighted the need to develop interventions to reduce school absenteeism and to ensure that children with type 1 diabetes are able to attain needed education.
FDA issues second CRL for dasiglucagon to treat hypoglycemia in congenital hyperinsulinism
Published: October 8th 2024 | Updated: October 8th 2024This decision marks the second time the FDA has issued a complete response letter (CRL) for dasiglucagon to treat hypoglycemia in patients 7 days and up with congenital hyperinsulinism.